ライフサイエンスコーパス: antimicrobial susceptibility test

1 y of an isolate allows for strain typing and antimicrobial susceptibility testing).

2 phoresis, extended virulence genotyping, and antimicrobial susceptibility testing.

3 demonstrated an added value for LC-MS/MS in antimicrobial susceptibility testing.

4 ria promulgated by the European Committee on Antimicrobial Susceptibility Testing.

5 Antimicrobial susceptibility testing.

6 t bacilli smears, and microbial cultures and antimicrobial susceptibility testing.

7 nating the need for biochemical analysis and antimicrobial susceptibility testing.

8 ime needed for phenotypic identification and antimicrobial susceptibility testing.

9 gel electrophoresis (PFGE), serotyping, and antimicrobial susceptibility testing.

10 quence typing (MLST), plasmid profiling, and antimicrobial susceptibility testing.

11 ted by the NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing.

12 tion's External Quality Assurance System for Antimicrobial Susceptibility Testing.

13 Agar dilution was used to conduct antimicrobial susceptibility testing.

14 -genome short-read sequencing and additional antimicrobial susceptibility testing.

15 to broth microdilution (BMD) for performing antimicrobial susceptibility testing.

16 and was approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing.

17 serotyping, multilocus sequence typing, and antimicrobial susceptibility testing.

18 sm identification and automated-system-based antimicrobial susceptibility testing.

19 for broad-based bacterial identification or antimicrobial susceptibility testing.

20 nce of accurate organism identification, and antimicrobial susceptibility testing.

21 bolic profiling provides an avenue for rapid antimicrobial susceptibility testing.

22 Antimicrobial susceptibility tests against thirteen anti

23 tandards Institute and European Committee on Antimicrobial Susceptibility Testing agree that carbapen

24 Typhi strains has emerged worldwide, making antimicrobial susceptibility testing an important functi

25 Antimicrobial susceptibility test and report guidelines

26 s of 2004 to 2005 and 2009 to 2010 underwent antimicrobial susceptibility testing and characterizatio

27 or additional characterization that included antimicrobial susceptibility testing and detection of fi

28 pulsed-field gel electrophoresis (PFGE) and antimicrobial susceptibility testing and examined for th

29 ne can expect to see changes in guidance for antimicrobial susceptibility testing and interpretation.

30 Isolates of C. difficile underwent antimicrobial susceptibility testing and molecular typin

31 Antimicrobial susceptibility testing and pulsed-field ge

32 Antimicrobial susceptibility testing and pulsed-field ge

33 istance mechanisms in staphylococci, current antimicrobial susceptibility testing and reporting recom

34 Isolates underwent antimicrobial susceptibility testing and subtyping by pu

35 Antimicrobial susceptibility testing and whole genome se

36 We performed antimicrobial susceptibility testing and whole genome se

37 Antimicrobial susceptibility tests and analysis of genom

38 ion between the results of existing in vitro antimicrobial susceptibility tests and clinical outcome

39 ovides an effective quantitative measure for antimicrobial susceptibility testing, and determination

40 e now using WGS for pathogen identification, antimicrobial susceptibility testing, and epidemiologica

41 by the VITEK 2 system for identification and antimicrobial susceptibility testing, and the results we

42 terized with routine identification systems, antimicrobial susceptibility testing, and whole-genome s

43 Serotyping, antimicrobial susceptibility testing, and whole-genome s

44 Serotyping/grouping, antimicrobial susceptibility testing, and/or whole genom

45 In January 2015, the CLSI Subcommittee on Antimicrobial Susceptibility Testing approved these rang

46 n methods and the lengthy turnaround time of antimicrobial susceptibility testing are significant bar

47 which were outside of the United States, for antimicrobial susceptibility testing as part of the Worl

48 Our results suggest that a rapid and robust antimicrobial susceptibility test (AST) can be construct

49 A vast amount of antimicrobial susceptibility test (AST) data is generate

50 icular, the absence of FDA-cleared automated antimicrobial susceptibility test (AST) devices that use

51 Cascade reporting of the antimicrobial susceptibility test (AST) is a strategy us

52 Patient-level antimicrobial susceptibility test (AST) results for Ente

53 Accurate and rapid antimicrobial susceptibility test (AST) results from pos

54 rmation from microbial genomes together with antimicrobial susceptibility test (AST) results.

55 y Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing (AST SC) is a volun

56 Accurate antimicrobial susceptibility testing (AST) and appropria

57 Accurate antimicrobial susceptibility testing (AST) and reporting

58 Here, we report a single cell antimicrobial susceptibility testing (AST) approach for

59 , from 56 patients, classified by phenotypic antimicrobial susceptibility testing (AST) as showing re

60 system for rapid pathogen classification and antimicrobial susceptibility testing (AST) at the single

61 Accurate and timely performance of antimicrobial susceptibility testing (AST) by the clinic

62 Routine antimicrobial susceptibility testing (AST) can prevent d

63 As a result, AZI antimicrobial susceptibility testing (AST) cannot be int

64 Traditional antimicrobial susceptibility testing (AST) confirmed a h

65 . Food and Drug Administration (FDA)-cleared antimicrobial susceptibility testing (AST) devices compa

66 The long turnaround time in antimicrobial susceptibility testing (AST) endangers pat

67 Clinical justification for rapid antimicrobial susceptibility testing (AST) in Gram-negat

68 As such, antimicrobial susceptibility testing (AST) is a cornerst

69 Antimicrobial susceptibility testing (AST) is a fundamen

70 Antimicrobial susceptibility testing (AST) is an essenti

71 a identification (ID) and rapid yet reliable antimicrobial susceptibility testing (AST) is developed.

72 The speed of conventional antimicrobial susceptibility testing (AST) is intrinsica

73 Antimicrobial susceptibility testing (AST) is not routin

74 Antimicrobial susceptibility testing (AST) is often used

75 Antimicrobial susceptibility testing (AST) is required f

76 A sufficiently fast and simple antimicrobial susceptibility testing (AST) is urgently r

77 ds and guidelines (among other products) for antimicrobial susceptibility testing (AST) methods and r

78 Conventional antimicrobial susceptibility testing (AST) methods requi

79 Previously, interpretative criteria and antimicrobial susceptibility testing (AST) methods speci

80 ating an urgent need for rapid and sensitive antimicrobial susceptibility testing (AST) methods to gu

81 Three commercial antimicrobial susceptibility testing (AST) methods were

82 Current antimicrobial susceptibility testing (AST) methods, howe

83 oenix system for the identification (ID) and antimicrobial susceptibility testing (AST) of 251 isolat

84 At present, in vitro antimicrobial susceptibility testing (AST) of aztreonam-

85 Antimicrobial susceptibility testing (AST) of cefideroco

86 Sparks, MD) for the identification (ID) and antimicrobial susceptibility testing (AST) of challenge

87 Antimicrobial susceptibility testing (AST) of clinical i

88 signed for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically

89 Antimicrobial susceptibility testing (AST) of pneumococc

90 Accurate and reproducible antimicrobial susceptibility testing (AST) of polymyxin

91 Identification (ID) and antimicrobial susceptibility testing (AST) of respirator

92 Antimicrobial susceptibility testing (AST) of these isol

93 Antimicrobial susceptibility testing (AST) of these prob

94 Antimicrobial susceptibility testing (AST) provides valu

95 id and reliable bacterial identification and antimicrobial susceptibility testing (AST) remain challe

96 Antimicrobial susceptibility testing (AST) reporting and

97 Current gold-standard antimicrobial susceptibility testing (AST) requires exte

98 Among 47 isolates from patients with antimicrobial susceptibility testing (AST) results avail

99 rovide rapid species identification (ID) and antimicrobial susceptibility testing (AST) results for t

100 The present study compared the antimicrobial susceptibility testing (AST) results gener

101 culture with microbial growth accompanied by antimicrobial susceptibility testing (AST) results in th

102 Concurrently, species, temporal trends, and antimicrobial susceptibility testing (AST) results of Le

103 ast majority of bacterial identification and antimicrobial susceptibility testing (AST) results were

104 stem (AXDX) provides identification (ID) and antimicrobial susceptibility testing (AST) results withi

105 Based on these data, the CLSI antimicrobial susceptibility testing (AST) subcommittee

106 boring MRSA, including three (semi)automated antimicrobial susceptibility testing (AST) systems and f

107 Antimicrobial susceptibility testing (AST) systems are t

108 Antimicrobial susceptibility testing (AST) technologies

109 stance has prompted the development of rapid antimicrobial susceptibility testing (AST) technologies

110 sistant Klebsiella pneumoniae demands faster antimicrobial susceptibility testing (AST) to guide anti

111 atory practice in the preanalytical phase of antimicrobial susceptibility testing (AST) was evaluated

112 report form was completed for each case and antimicrobial susceptibility testing (AST) was performed

113 determining the optimal frequency of repeat antimicrobial susceptibility testing (AST) when an organ

114 Antimicrobial susceptibility testing (AST) with 13 agent

115 Rapid antimicrobial susceptibility testing (AST) would decreas

116 ISA (hVISA) are pathogens for which accurate antimicrobial susceptibility testing (AST) would rule ou

117 harmacokinetics (PK), pharmacodynamics (PD), antimicrobial susceptibility testing (AST), and how thes

118 AMR is identified through antimicrobial susceptibility testing (AST), but current

119 k of a rapid pathogen identification (ID) or antimicrobial susceptibility testing (AST), resulting in

120 phokinetic bacterial analysis for phenotypic antimicrobial susceptibility testing (AST), with promisi

121 assay was adapted for use in broad-spectrum antimicrobial susceptibility testing (AST).

122 ng with the ability to perform culture-based antimicrobial susceptibility testing (AST).

123 AMR are clinical laboratories, which perform antimicrobial susceptibility testing (AST).

124 th microdilution (BMD) method for performing antimicrobial susceptibility testing (AST).

125 h micro-dilution (BMD) method for performing antimicrobial susceptibility testing (AST).

126 sequencing bacterial strains and performing antimicrobial susceptibility testing (AST).

127 orimetric sensing strategy was developed for antimicrobial susceptibility testing (AST).

128 which requires bacterial identification and antimicrobial susceptibility testing (AST).

129 Current gold standard antimicrobial susceptibility tests (AST) rely on organis

130 is an urgent need to develop simple and fast antimicrobial susceptibility tests (ASTs) that allow inf

131 n and facilitates rapid bacterial growth for antimicrobial susceptibility testing at the point of car

132 large surface-to-volume ratio, toward rapid antimicrobial susceptibility testing at the point of car

133 dy were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing at their June 2015

134 simple microfluidic device that can perform antimicrobial susceptibility testing automatically via a

135 with an MIC above the European Committee on Antimicrobial Susceptibility Testing breakpoint) when ac

136 ndards Institute revised the fluoroquinolone antimicrobial susceptibility testing breakpoints for bot

137 o 21.7%) using CLSI or European Committee on Antimicrobial Susceptibility Testing breakpoints.

138 Antimicrobial susceptibility testing, broth enriched cul

139 All isolates were identified and underwent antimicrobial susceptibility testing by broth microdilut

140 CRE isolates underwent antimicrobial susceptibility testing by broth microdilut

141 through 10 May 2016 underwent routine Etest antimicrobial susceptibility testing by the Hawaii Depar

142 enotypic analysis, including biochemical and antimicrobial susceptibility testing, cellular fatty aci

143 Here, we show that personalised antimicrobial susceptibility testing could help tackle a

144 em, were determined by the dielectrophoretic antimicrobial susceptibility testing (dAST) and by the c

145 ical clustering results for MS, genomic, and antimicrobial susceptibility test data to hierarchical c

146 important implications for interpretation of antimicrobial susceptibility testing data and may be imp

147 Notably, antimicrobial susceptibility testing demonstrated good o

148 support from technical representatives from antimicrobial susceptibility testing device manufacturer

149 As such, our antimicrobial susceptibility testing diagnostic and surv

150 or =1 microg/ml by the European Committee on Antimicrobial Susceptibility Testing]; disk diffusion br

151 tion's External Quality Assurance System for Antimicrobial Susceptibility Testing (EQAS-AST) from Jan

152 ed in this article, the CLSI Subcommittee on Antimicrobial Susceptibility Testing established new bre

153 ptibility testing, the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Cl

154 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) are 2 glob

155 ntly, clinical FDA and European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint

156 When evaluated using European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoint

157 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth micr

158 s Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) epidemiolo

159 stitute (CLSI)-FDA and European Committee on Antimicrobial Susceptibility Testing (EUCAST) interpreti

160 s Institute (CLSI) and European Committee of Antimicrobial Susceptibility Testing (EUCAST) methodolog

161 k breakpoints, and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) S. pseudin

162 on (BMD) method of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) was compar

163 stitute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST), respectiv

164 inistration (FDA), and European Committee on Antimicrobial Susceptibility Testing (EUCAST).

165 e data collated by the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

166 stitute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST).

167 Antimicrobial susceptibility testing expense may be a si

168 Bacteria were identified by MALDI-TOF, antimicrobial susceptibility testing followed EUCAST gui

169 ionization-time of flight mass spectrometry, antimicrobial susceptibility testing followed European C

170 ew method developed and evaluated as a rapid antimicrobial susceptibility test for B. anthracis This

171 enterococci following a laboratory change in antimicrobial susceptibility testing from disk diffusion

172 Accelerating antimicrobial susceptibility testing from positive blood

173 ility testing followed European Committee on Antimicrobial Susceptibility Testing guidelines.

174 The NCCLS Subcommittee for Veterinary Antimicrobial Susceptibility Testing has recently approv

175 ofluidic device provides a simple method for antimicrobial susceptibility testing in an automated for

176 ds were approved by the CLSI Subcommittee on Antimicrobial Susceptibility Testing in January 2015 and

177 to 0.5/4 mug/mL) by the CLSI Subcommittee on Antimicrobial Susceptibility Testing in January 2022.

178 terobacteriaceae family poses a challenge to antimicrobial susceptibility testing in the clinical lab

179 Antimicrobial susceptibility testing in the presence of

180 tandards Institute and European Committee on Antimicrobial Susceptibility Testing interpretative stan

181 Antimicrobial susceptibility testing is a critical compo

182 Antimicrobial susceptibility testing is a critical compo

183 Antimicrobial susceptibility testing is a key weapon aga

184 The applicability of microfluidic rapid antimicrobial susceptibility testing is demonstrated in

185 Because antimicrobial susceptibility testing is not routinely do

186 Antimicrobial susceptibility testing is routinely perfor

187 Accurate antimicrobial susceptibility testing is vital for patien

188 Antimicrobial-susceptibility testing is performed to det

189 Current planktonic-based antimicrobial susceptibility testing lacks the ability t

190 annual update, the Performance Standards for Antimicrobial Susceptibility Testing (M100).

191 f identification to bacterial species level, antimicrobial susceptibility testing, macrolide resistan

192 health, we advocate for the use of stringent antimicrobial susceptibility test method evaluation proc

193 atory Standards Institute (CLSI) revised the antimicrobial susceptibility testing method for telavanc

194 should consider using a second, independent antimicrobial susceptibility testing method to validate

195 Each organism was tested by the routine antimicrobial susceptibility testing method used by each

196 train was tested by the laboratory's routine antimicrobial susceptibility testing method.

197 g was performed by the European Committee on Antimicrobial Susceptibility Testing methodology.

198 up organisms on the selection of appropriate antimicrobial susceptibility testing methods and interpr

199 Diffusion-based antimicrobial susceptibility testing methods are not rec

200 However, the accuracy of some antimicrobial susceptibility testing methods for detecti

201 To assess the abilities of various antimicrobial susceptibility testing methods to detect E

202 ploying accurate, reproducible, and feasible antimicrobial susceptibility testing methods to guide ap

203 achieved 95% overall agreement with standard antimicrobial susceptibility testing methods, with the h

204 WGS was as sensitive and specific as routine antimicrobial susceptibility testing methods.

205 me geographic area using broth microdilution antimicrobial susceptibility testing, multilocus sequenc

206 Significantly, the results of antimicrobial susceptibility testing obtained for our is

207 Antimicrobial susceptibility testing of 53 strains, incl

208 Antimicrobial susceptibility testing of 66 isolates reve

209 uld be developed, and the optimal method for antimicrobial susceptibility testing of A. xylosoxidans

210 Thus, the antimicrobial susceptibility testing of B. pertussis can

211 Present methods of antimicrobial susceptibility testing of Bordetella pertu

212 tion and the agar disk diffusion methods for antimicrobial susceptibility testing of Campylobacter we

213 t represents an accurate tool for performing antimicrobial susceptibility testing of Enterobacterales

214 Antimicrobial susceptibility testing of isolates from 47

215 as been used to reduce the time required for antimicrobial susceptibility testing of Mycobacterium tu

216 s for the performance and quality control of antimicrobial susceptibility testing of Mycoplasma pneum

217 methods decrease the time to identification/antimicrobial susceptibility testing of S. aureus and de

218 ods take several days for identification and antimicrobial susceptibility testing of staphylococcal i

219 in S. aureus, Vitek 2 performed reliably for antimicrobial susceptibility testing of staphylococci an

220 It appears to be an acceptable method for antimicrobial susceptibility testing of staphylococci an

221 Seven commercial systems for antimicrobial susceptibility testing of Streptococcus pn

222 control limits and interpretive criteria for antimicrobial susceptibility testing of Streptococcus pn

223 In vitro antimicrobial susceptibility testing of the conjugate ag

224 Antimicrobial susceptibility testing of the samples iden

225 Antimicrobial susceptibility testing of these cobalt com

226 onas maltophilia at this time, and, as such, antimicrobial susceptibility testing of these organisms

227 lity control (QC) standards for the in vitro antimicrobial susceptibility testing of two fastidious v

228 The utility of Etest for antimicrobial susceptibility testing of Yersinia pestis

229 We performed antimicrobial susceptibility testing on all 2767 sero19A

230 Culture, antimicrobial susceptibility testing, P1 subtyping, and

231 A bloodstream isolates were characterized by antimicrobial susceptibility testing, PCR analysis of vi

232 Isolates were serotyped and antimicrobial susceptibility testing performed.

233 e isolates were characterized by serotyping, antimicrobial-susceptibility testing, phage typing, and

234 Here, we present a capillary-based antimicrobial susceptibility testing platform (cAST), a

235 For genotypic antimicrobial susceptibility testing prediction, the per

236 The isolates underwent antimicrobial susceptibility testing, pulsed-field gel e

237 ble S. aureus isolates were characterized by antimicrobial-susceptibility testing, pulsed-field gel e

238 The delayed reporting of antimicrobial susceptibility testing remains a limiting

239 ysis interpretation, culture thresholds, and antimicrobial susceptibility testing, require special co

240 ) CD-ROM on AST, and (iv) the CDC Multilevel Antimicrobial Susceptibility Testing Resource website.

241 pes and correlated with available phenotypic antimicrobial susceptibility test results and genotypic

242 Antimicrobial susceptibility test results for trimethopr

243 Because antimicrobial susceptibility test results impact far mor

244 cultures, and BD Phoenix identification and antimicrobial susceptibility test results were comparabl

245 tes, and show that cAST can deliver accurate antimicrobial susceptibility test results within 4-8 h.

246 high degree of correlation of serotyping and antimicrobial susceptibility testing results between fou

247 increased the importance of having accurate antimicrobial susceptibility testing results for guiding

248 We compared the antimicrobial susceptibility testing results generated b

249 logical testing, including interpretation of antimicrobial susceptibility testing results using curre

250 tem (AXDX) provides rapid identification and antimicrobial susceptibility testing results.

251 NS category, the organism identification and antimicrobial-susceptibility test results should be conf

252 Antimicrobial susceptibility testing revealed several di

253 Antimicrobial susceptibility testing revealed universal

254 tant but clindamycin susceptible by in vitro antimicrobial susceptibility testing should be tested fo

255 Based on these findings, we recommend that antimicrobial susceptibility testing should not be routi

256 Antimicrobial susceptibility testing showed that oxazoli

257 al and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Subcommittee evalua

258 ified selection for changes in motility, and antimicrobial susceptibility testing suggested that the

259 ed in conjunction with the VITEK 2 automated antimicrobial susceptibility test system to ascertain th

260 nc., Durham, NC) is a widely used commercial antimicrobial susceptibility test system.

261 nc., Durham, NC) is a widely used commercial antimicrobial susceptibility testing system.

262 pid quantitative PCR (qPCR)-based phenotypic antimicrobial susceptibility test that utilizes amplific

263 leading organizations that set standards for antimicrobial susceptibility testing, the European Commi

264 In antimicrobial susceptibility tests, this cephalothin ana

265 apid ID 32 Strep identification methods, and antimicrobial susceptibility testing to determine their

266 d characterization methods, from traditional antimicrobial susceptibility testing to recent deep-lear

267 , relevant interpretations of the results of antimicrobial susceptibility tests to clinicians, clinic

268 esis (PFGE) following SmaI macrorestriction, antimicrobial susceptibility testing, urease production,

269 human clinical specimens, were subjected to antimicrobial susceptibility testing using a MicroScan W

270 We present a method for rapid and scalable antimicrobial susceptibility testing using stationary na

271 Antimicrobial susceptibility testing using the agar dilu

272 Antimicrobial susceptibility testing using the Sensititr

273 by conventional microbiological methods, and antimicrobial susceptibility test was done by disc diffu

274 Antimicrobial susceptibility test was performed accordin

275 Antimicrobial susceptibility testing was also conducted.

276 Antimicrobial susceptibility testing was conducted for E

277 lobacter spp. and E. coli were isolated, and antimicrobial susceptibility testing was conducted using

278 e and SCCmec typing were assessed by PCR and antimicrobial susceptibility testing was done according

279 Antimicrobial susceptibility testing was performed by Se

280 Antimicrobial susceptibility testing was performed by st

281 Antimicrobial susceptibility testing was performed follo

282 Antimicrobial susceptibility testing was performed on 21

283 Antimicrobial susceptibility testing was performed on Bc

284 Antimicrobial susceptibility testing was performed using

285 Antimicrobial susceptibility testing was performed using

286 Antimicrobial susceptibility testing was performed, and

287 Antimicrobial susceptibility testing was used to define

288 Whole genome sequencing and antimicrobial susceptibility testing were done on 168 co

289 ngoing national surveillance, serotyping and antimicrobial susceptibility testing were done on all pn

290 culture, manual speciation, serotyping, and antimicrobial susceptibility testing were performed at M

291 Pneumococcal serotyping and antimicrobial susceptibility testing were performed on 4

292 apid ID 32 Strep identification methods; and antimicrobial susceptibility testing were performed on t

293 Whole genome sequencing (WGS) and antimicrobial susceptibility testing were performed to e

294 Culture-based identification methods and antimicrobial susceptibility testing were used as the re

295 Antimicrobial susceptibility tests were done by the disc

296 Antimicrobial susceptibility tests were performed by the

297 Antimicrobial susceptibility testing, whole-genome seque

298 i clinical strain WCHEC13-8 was subjected to antimicrobial susceptibility tests, whole genome sequenc

299 od, Mo.), an established automated method of antimicrobial susceptibility testing with the ability to

300 c device that was capable of executing rapid antimicrobial susceptibility tests with one, two, or eve